Assura Plc (ARSSF)
| Market Cap | 2.18B |
| Revenue (ttm) | 220.35M |
| Net Income (ttm) | 88.59M |
| Shares Out | n/a |
| EPS (ttm) | 0.03 |
| PE Ratio | 24.62 |
| Forward PE | 14.10 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,000 |
| Average Volume | 156 |
| Open | 0.7125 |
| Previous Close | 0.6930 |
| Day's Range | 0.6055 - 0.7125 |
| 52-Week Range | 0.4320 - 0.7125 |
| Beta | 0.62 |
| RSI | 99.16 |
| Earnings Date | May 15, 2025 |
About Assura
Assura plc is the UK's leading specialist healthcare property investor and developer. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served. A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA indices. As at 31 March 2024, Assura's portfolio was valued at £2.7 billion and has a strong track record of growing financial returns and dividends for shareholders. At Assura, we BUILD for health, having developed over 100 new hea... [Read more]
Financial Performance
In 2023, Assura's revenue was 157.80 million, an increase of 4.92% compared to the previous year's 150.40 million. Losses were -28.80 million, -75.84% less than in 2022.
Financial numbers in GBP Financial StatementsNews
KKR Fails to Get Any Acceptances for $2.32 Billion Assura Takeover Bid
Dimensional Fund Advisors Ltd. : Form 8.3 - ASSURA PLC - Ordinary Shares
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (...
Competition watchdog to probe takeover of NHS landlord Assura
Rival healthcare property firm PHP has agreed to buy Assura for £1.79 billion.
Top investors in GP surgery firm Assura oppose £1.7bn bid from US private equity giant KKR
Top ten investors Quilter Cheviot and Schroders said they favour a deal with London-listed rival Primary Health Properties over US buyout giant KKR.
KKR-led bid for NHS landlord Assura hit by shareholder opposition
Some investors worry about another UK company being taken private at a valuation they see as too low
Assura urged to reject bid from predator KKR
Primary Health Properties offered £1.68billion to buy Assura but it argued that its cash and stock bid is now worth more.
Assura Agrees to Sweetened $2.29 Billion Takeover Offer From KKR, Stonepeak
US private equity giant KKR wins takeover battle for Assura in £1.7bn deal
Assura said it had reached an agreement on a ‘best and final’ bid led by Kohlberg Kravis Roberts and Stonepeak Partners.
Private equity consortium strikes £1.7bn deal for NHS landlord
KKR and Stonepeak reach agreement to buy London-listed Assura
UK Stock Market News: GlobalData, Ibstock, Assura
GlobalData bid talks abandoned, Ibstock trading update shows market recovery but margin headwinds, final offer tabled for Assura
Doctors’ surgeries bid battle is shot in the arm for UK property
Takeover tussle for NHS landlord Assura has spurred investors to reconsider the value of UK real estate assets
Northwest Healthcare Properties Real Estate Investment Trust sells remaining stake in Assura for $139.3M
M&A Snapshot: KKR, Stonepeak to acquire UK's Assura in $2.06 billion all-cash deal
UK's Assura agrees to $2 billion takeover offer by KKR-Stonepeak
GP surgeries owner Assura agrees to private equity takeover worth £1.61bn
The London-listed company will be bought by Kohlberg Kravis Roberts (KKR) and Stonepeak Partners.
UK Stock Market News: SAGA, Assura, PageGroup
SAGA, Assura and PageGroup feature as Tony Cross's three headlines from today's London stock market open
UK Stock Market News: Chapel Down, Currys, Assura
Profit upgrade at Currys, Chapel Down shows resilience despite weak consumer market, Primary Health revises Assura offer